Some of these clones have also been regionally mapped to specific sites of chromosome 21 by using a regional mapping panel of cell hybrids. This chromosome microtechnology can generate large numbers of microclones with unique sequences from defined chromosomal regions and can be used for processes such as (i) isolating corresponding yeast artificial chromosome clones with large inserts, (ii) screening various cDNA libraries for isolating expressed sequences, and (iii) constructing region-specific libraries of the entire human genome. The studies described here demonstrate the power of this technology for high-resolution genome analysis and explicate their use in an efficient search for disease-associated genes localized to specific chromosomal regions. Molecular analysis and fine structure mapping of the human genome require isolation of large numbers of DNA probes from defined regions of the chromosomes (1, 2) . In addition, the effective use of genetic linkage analysis with polymorphic DNA probes from the human genome has localized more and more inherited diseases of unknown etiology, as well as specific forms of cancer, to refined regions of various chromosomes (3) . Thus, the next major task is to isolate the genes underlying these diseases for better understanding, prevention, diagnosis, and treatment of the disease.
A direct approach to this objective, as proposed by Edstrom and his colleagues (4) , is to use the chromosome microdissection technique to remove physically the chromosomal region of interest and to clone the minute quantities of the dissected chromosomal DNA by a microcloning procedure. This approach has been successfully applied first with the Drosophila polytene chromosome (4) and later with the mammalian metaphase chromosome (5) .
Recently, a modification of this method was described by Ludecke et al. (6) in which significantly increased cloning efficiency was achieved by ligation of the dissected chromosomal DNA to a vector, followed by polymerase chain reaction (PCR) to amplify the dissected sequences. The PCR products were cloned into the plasmid vector pUC13. Using this method, these investigators obtained between 5000 and 20,000 clones from each ofthe dissected chromosome regions (6) (7) (8) (9) . The advantages of this method over the original microcloning procedure include (i) banded and stained chromosome preparations can be used, (ii) fewer dissected chromosome fragments are needed, and (iii) large numbers of microclones can be obtained.
Another method of PCR microcloning was described by Saunders et al. (10) and by Johnson (11) for a universal amplification of microdissected Drosophila polytene chromosome fragments. In this method, a polytene chromosome band was dissected, cleaved with either Sau3A or Mbo 1, and ligated to a linker adaptor. The linker adaptor was constructed from oligonucleotides of 24-mer and 20-mer annealed to yield a 5' protruding Sau3A or Mbo I sequence. The 20-mer of the linker adaptor was used as a primer for PCR. The amplified products were digested again with Sau3A or Mbo I and cloned into the compatible BamHI site ofa plasmid vector. Large numbers of clones were obtained by this method. More importantly, Saunders et al. (10) also compared the PCR microcloning method with the conventional microcloning method and showed that the PCR method generated probes representing >90% of the dissected genomic region, whereas the probes from the conventional method covered only 3-4% of the same dissected region. Moreover, the PCR microcloning by the linker-adaptor method appears to offer additional useful features over the PCR microcloning method of Ludecke et al. (6) : (i) several different linker sequences and restriction enzymes can be used, and (ii) a more efficient sticky-end ligation, instead of blunt-end ligation, is used.
We have been interested in this chromosome microtechnology and have developed competence in microdissection of human chromosomes and the conventional microcloning technique, as described (1, 2) . Because the PCR microcloning method offers significant advantages over conventional microcloning, we have adopted the Mbo I linker-adaptor technique into our microcloning procedure to amplify microdissected human chromosome sequences for cloning into the plasmid vector pUC19. Here (2) . Mitotic cells were harvested and fixed in 100% methanol instead of acetic acid/methanol (1:3) to avoid possible acid damage to the chromosomal DNA as described (2) .
Chromosome Microdissection. We dissected the entire human chromosome 21 as the cloning material. In each microcloning experiment, 30 chromosomes were dissected with a de Fonbrune micromanipulator and the Leitz Laborlux D-FS high focal length microscope as described (2) . Glass microneedles with fine tips were constructed with a de Fonbrune microforge (12) . The dissected chromosomes were assembled in a microdrop of proteinase K (stock solution, 0.5 mg of proteinase K per ml in 10 mM Tris HCl, pH 7.5/10 mM NaCl/0.1% SDS), which was placed on a glass slide and covered with a larger drop of buffer-saturated paraffin oil (Merck 7162). No oil chamber was used.
Preparation of Microdissected Chromosome DNA. After dissection, a tiny drop of lOx fresh proteinase K was added to the original microdrop. The slide was incubated at 50'C for 2-3 hr to completely digest the protein of the chromosomes. The microdrop was then extracted three times with buffersaturated phenol (ultrapure; BRL) and once with chloroform as described (12) .
Preparation of Mbo I Linker Adaptor. The Mbo I linker adaptor was prepared by annealing two oligonucleotides of the following sequences as described by Johnson (11) : a 24-mer including 5'-GAT CTG TAC TGC ACC AGC AAA TCC-3' ofwhich the 5' end was phosphorylated, and a 20-mer including 3'-... .AC ATG ACG TGG TCG lTl AGG-5' with a dephosphorylated 5' end (prepared by Research Genetics, Huntsville, AL). While the phosphorylated 5' overhanging Mbo I end of the adaptor will ligate to the Mbo I-digested chromosomal DNA, the dephosphorylated 5' termini at the blunt end of the adaptor will prevent them from self-ligation to form long repeating units, which would interfere with amplification. The two oligonucleotides were annealed at 60°C for 1 hr, each at a concentration of 100 ,ug/ml. Universal Amplification of Chromosomal DNA by Linker Adaptor. After ligation, the microdrop was transferred to an Eppendorf tube for amplification (13) . The following PCR conditions were used: one cycle at 94°C for 5 min, at 45°C for 2 min, at 72°C for 3 min; 30 cycles at 94°C for 1.5 min, at 45°C for 2 min, at 72°C for 3 min; extension at 72°C for 10 min. The 20-mer of the adaptor was used as a primer. PCR was carried out in an automated thermal cycler (MicroCycler; Eppendorf).
Cloning into pUC19. After PCR, the amplified products were purified with Geneclean II (Bio 101, La Jolla, CA), digested with Mbo I, separated on agarose gel to remove adaptor molecules, purified again with Geneclean, ligated to dephosphorylated pUC19 vector (Boehringer Mannheim), and used in transformation with the highly efficient DH5a competent cells (BRL).
Characterization of Microclones. After transformation, ampicillin-resistant white colonies were individually isolated for initial characterization. For determining the unique or repetitive sequence nature of the insert, labeled total human DNA was hybridized to filters containing recombinant microclones, as described (14) . The insert size contained in the microclones was estimated by PCR in which specific primers flanking the cloning sites of pUC19 were used to amplify the insert sequence in each clone. Two sequences of 20-mer each were used as the primer: 5'-ACA GGA AAC AGC TAT GAC CA-3' and 5'-CGT TGT AAA ACG ACG GCC AG-3'. The bacterial colonies containing recombinant pUC19 were used directly in PCR and the amplified sequences were separated on a gel containing 2% NuSieve and 1% agarose.
Identification of Microclones Derived from Dissected Human
Chromosome 21. The PCR amplified products from each clone were used to prepare labeled probes for Southern hybridization to DNAs from human, cell hybrid 38-14 containing human chromosome 21, and the standard CHO. The PCR products were purified by Geneclean and labeled to high specific activities with [32P]dCTP by the primer-extension procedure (15) using both the random hexamers and the two specific primer sequences flanking the inserts. After separation on gel, the DNA was transferred to a Hybond-N+ nylon membrane (Amersham) for 2-3 hr by the alkali-blotting procedure (transfer buffer, 0.4 M NaOH), according to the manufacturer's protocol. The filters were prehybridized at 65°C for 2 hr before the probes were added at a concentration of 1-3 x 106 cpm/ml. Hybridization was carried out at 65°C for [16] [17] [18] [19] [20] hr. Stringent washing was used, including a final wash at 65°C for 10-20 min. The x-ray film was exposed for 2-4 days.
Regional Mapping of Microclones on Chromosome 21. A chromosome 21 regional mapping panel was kindly provided by David Patterson (Eleanor Roosevelt Institute). Only a partial panel including four hybrid lines was used: 153E7b (containing normal long arm), 21q+ (containing 21pter-q22.2), GA9-3 (containing 21q21.1-qter), and 1881c-13b (containing 21q21.3-qter). Detailed karyotypic analysis of these hybrids has been described (16) .
Precautions in Minimizing Extraneous DNA in Universal
Amplification. It is absolutely essential to enforce strict precautions to prevent introduction of contaminant DNA from extraneous sources into the highly sensitive process of universal amplification (17) (18) (19) . No glassware washed in a common facility was used; disposable plasticware was used instead. Autoclaved distilled water, buffers, and reagents were used. For materials that are not autoclavable, exposure to UV (254 nm) will render the extraneous DNA not amplifiable (18) . All buffers and reagents were prepared in an air-clean hood (19) and divided into small aliquots to be used only once and discarded. Similarly, all glass micropipettes constructed for microcloning were used only once and discarded. Only "safe" buffer was used to saturate paraffin oil and phenol. A control microdrop without insert DNA was always included in each PCR microcloning experiment; after PCR, if the control sample contained any trace of PCR products, the entire experiment was discarded. With these precautions strictly enforced, "mysterious" recombinant clones of unknown origin have been effectively excluded. sizes in these inserts ranged from 50 to 1100 base pairs (bp), with a mean length of 416 bp. All these 60 inserts have apparently different sizes. A gel showing the amplified inserts is shown in Fig. 4 . Thus, the insert sizes contained in our microclones are generally larger than those obtained by the method of Horsthemske and co-workers (6) (7) (8) (9) , which averaged between 150 and 217 bp.
RESULTS

Microdissection of Human
Demonstration of Human Origin and Chromosome 21 Specificity of the Microclones. Microclones were analyzed by Southern blot analysis to determine whether they were of human origin and chromosome 21 specific. Of 22 microclones analyzed, at least 19 were shown to be definitely human and chromosome 21 specific and 1 was from CHO. Typical hybridization results are presented in Fig. 5 for three of these microclones. All 19 clones hybridized to both human and hybrid 38-14 but not to CHO. The banding patterns in human and hybrid DNA are identical for each clone. Because the inserts were generated by Mbo I cleavage of the chromosomal DNA, the hybridizing genomic fragments cleaved with either HindIll or EcoRI had different sizes from the inserts. Thus, clone 21E-181 containing an insert of660 bp hybridized to a HindIII genomic fragment of 11.7 kilobases (kb) (Fig.  SA) . Clone 21E-199 containing an insert of 380 bp hybridized to a HindIII fragment of 13.2 kb (Fig. SB) . Clone 21E-56 containing an insert of 280 bp hybridized to a HindIll fragment of 14.1 kb (Fig. SC) and to an EcoRI fragment of 1.4 kb (Fig. 5D) .
No weak bands were detected in CHO, presumably because we used stringent hybridization and washing conditions in these experiments. However have been confirmed to be chromosome 21 specific, 16 clones are single-copy and three clones contain low-copy inserts. One microclone, which hybridized to CHO and the hybrid but not to human, could have resulted from dissection of a CHO chromosome. This can be avoided by using banded chromosomes.
Regional Mapping of Clones to Chromosome 21. We have regionally mapped two microclones on chromosome 21 by using a regional mapping panel developed in Patterson's laboratory (16) . Clone 21E-56 hybridized to DNA from hybrids 21q+, 159E7b, GA9-3, and 1881c-13b, thus mapping to the long arm of chromosome 21, region q21.3-q22.2, a region defined by hybrids 21q+ and 1881c-13b (16) . Clone 21E-181 also hybridized to these same four hybrids and was thus assigned to the same region. Because of the common occurrence of extraneous DNA unintentionally introduced into the samples during microdissection and microcloning, we have exercised highly stringent control to eliminate such contamination. This precaution is essential to ensure the absence of mysterious microclones in the library and to minimize .the efforts involved in the characterization of individual clones for their human origin and chromosome specificity.
DISCUSSION
The small insert sizes, averaging 300-400 bp, in the microclones may present an advantage in cloning genomic regions containing inverted repetitive sequences, which can form palindromic structures and often render the clones unstable (20) . A pair ofinverted repeats several hundred base pairs long each would appear too large to be included in most of the microclones, thus potentially reducing unclonable regions in the human genome.
It is relatively simple and efficient to isolate large numbers of microclones containing unique sequences by colony hybridization. At least half of the clones in the library can be expected to contain single or low-copy sequences. Thus, thousands of microclones with unique sequences can be conveniently isolated and used in screening other human genomic libraries for larger inserts. In an initial attempt, we used four of our unique sequence microclones to screen the human YAC library from Washington University (21) . This YAC library contains -56,000 clones (5 times the human genome equivalent) with a mean insert size of 250 kb. After two-thirds of the library was screened, five positive YAC clones were identified with inserts ranging from 50 to 360 kb. These experiments demonstrate the feasibility of using microclones with very small inserts (several hundred base pairs) to isolate corresponding large genomic fragments of several kilobases in the YAC clones. The YAC clones isolated from a chromosomal region can be used to establish contiguous sequences to cover the entire dissected genomic region. The short inserts contained in the pUC19 microclones can be conveniently sequenced to identify unique sequences to serve as "sequence-tagged sites" as proposed by Olson et al. (22) . Thus, the chromosome microtechnology described here fulfills our initial intention for gaining quick and direct access to a defined human chromosomal region to isolate large numbers of clones to facilitate genomic analysis and search for disease genes (1, 2).
The availability of large numbers of unique sequence probes from an important chromosomal region is also valuable in screening various cDNA libraries for isolating expressed sequences from the region. This approach is particularly appealing because (i) cDNA sequences have functional significance and are valuable materials for early phases of genomic sequencing, and (ii) cDNA clones isolated from relevant tissues can serve as candidate genes for an effective search for particular disease genes assigned to the region. We have already begun to use this approach to attempt to isolate as many cDNA clones as possible from human chromosome 21. Filters containing Agtl1 phage plaques from a human liver cDNA library were screened with our chromosome 21 microclones identified to possess only unique sequences. Inserts from these microclones were independently amplified and the amplified inserts were pooled, 10 clones in a group, to prepare labeled probes. After screening 100,000 phage from the cDNA library probed with 100 unique sequence microclones, at least 4 positive cDNA clones were identified. Since the number of cloned genes on chromosome 21 is still (1991) limited, 16 genes cloned so far (3), a large collection of cDNA clones from chromosome 21 isolated by this approach should be extremely useful as candidate genes for the search of specific genes underlying Down syndrome and other neurological diseases on this chromosome. The chromosome microtechnology described here can be used for molecular structure and sequence organization analyses of interesting cytogenetic landmarks-e.g., centromeres, telomeres, fragile sites, centric heterochromatin, acentric double minutes, centric minichromosomes, homogeneously staining regions, translocation and deletion breakpoints, and unstable chromosome regions.
This microtechnology is also useful in providing regionspecific probes to fill large gaps that currently exist in the genetic linkage maps where DNA probes are sparse or nonexistent-e.g., the large gaps (>40 centimorgans) in lq, 2p, 6p, 8q, 9p, lOp, 11q, 12q, 13q, 14q, 15q, 17q, 18q, etc. (23) . Microdissection can be directed to these regions and highly polymorphic microclones can be identified and used for this purpose.
The analysis of the human genome and the search for disease genes are both challenging and rewarding. These studies require development of many powerful molecular genetic approaches and methodologies. A better understanding of the human genome should provide insight into the structure and functional relationships of specific genes and DNA sequences in normal and diseased states. Successful isolation of genes underlying genetic diseases may lead to prevention, diagnosis, and therapy of many devastating diseases, including cancer. The chromosome microtechnology described here appears to offer an additional powerful methodology to achieve these goals.
